Skip to main content
. Author manuscript; available in PMC: 2018 Jul 21.
Published in final edited form as: J Mol Biol. 2017 May 11;429(15):2290–2307. doi: 10.1016/j.jmb.2017.05.010

Table 1.

HIV-1 and HIV-2 vectors for comparative parallel analyses of viral mutagenesis by single-strand consensus sequencing.a

Virus Reference HIV Type RT Subtype or Groupb Identity to NL4-3 RTc Identity to ROD14 RTc
94CY017.41 [79] HIV-1 A 90% 62%
NL4-3 [77] HIV-1 B 62%
YU2 [80, 81] HIV-1 B 97% 61%
BH10 [82] HIV-1 B 97% 61%
93BR029.4 [83] HIV-1 B 97% 62%
MJ4 [84] HIV-1 C 93% 61%
96ZM651.8 [85] HIV-1 C 93% 61%
98IS002.5 [85] HIV-1 C 93% 61%
94UG114.1.6 [83] HIV-1 D 92% 61%
92NG003.1 [83] HIV-1 G 90% 62%
ROD14 [78] HIV-2 A 62%
ST [86, 87] HIV-2 A 61% 93%
ISY [92] HIV-2 A 62% 93%
D194 [88, 89] HIV-2 A 61% 90%
CBL-20 [90] HIV-2 A 62% 93%
GH123 [93] HIV-2 A 63% 93%
a

A panel of 10 HIV-1 and 6 HIV-2 vectors was created by sub-cloning reverse transcriptase (RT) genes from other HIV-1 vectors into pNL4-3 MIG or from other HIV-2 vectors (or from genomic DNA purified from cells infected with HIV-2) into pROD14 MIG in a near-isogenic fashion (see Methods).

b

HIV-1 vectors were engineered with RTs from multiple subtypes of Group M, especially subtypes B (the predominant subtype in the U.S.) and C (the predominant subtype globally). All HIV-2 vectors were engineered with RTs from Group A.

c

The columns indicate the extent of identity between RT sequences at the amino acid level.